Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
BACKGROUND: Malaria in pregnancy increases the risk of maternal anemia, abortion and low birth weight. Approximately 85.3 million pregnancies occur annually in areas with Plasmodium falciparum transmission. Pregnancy has been reported to alter the pharmacokinetic properties of many anti-malarial dru...
Κύριοι συγγραφείς: | Tarning, J, Kloprogge, F, Piola, P, Dhorda, M, Muwanga, S, Turyakira, E, Nuengchamnong, N, Nosten, F, Day, N, White, N, Guerin, P, Lindegardh, N |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
BioMed Central
2012
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Uganda
ανά: Tarning Joel, κ.ά.
Έκδοση: (2012-08-01) -
Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.
ανά: Tarning, J, κ.ά.
Έκδοση: (2013) -
Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2013) -
Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
ανά: Kloprogge, F, κ.ά.
Έκδοση: (2014) -
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
ανά: Piola, P, κ.ά.
Έκδοση: (2010)